The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
"There are so many options for hysterectomies now that patients should discuss the pros and cons of all of them with their doctors," said the study's lead author, CUMC's Dr. Jason Wright.
5 new leukemia clinician-scientists have joined the Herbert Irving Comprehensive Cancer Center at NYPH/CUMC: Drs. Mark Frattini, Mark Heaney, Joseph Jurcic, Nicole Lamanna, & Todd Rosenblat.
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center has welcomed five new clinician-scientists specializing in leukemia.